The Traderszone Network

Published in TZ Latest News 2 August, 2017 by The TZ Newswire Staff

Here’s Why Spark Therapeutics Inc. Is Soaring Today

After reporting second-quarter results that contained upbeat clinical news, Spark Therapeutics (NASDAQ: ONCE), a clinical-stage company focused on gene therapy, rose 18% as of 12:30 p.m. EDT on Wednesday.

Here’s a review of the key highlights from the quarter that have traders feeling giddy today:

read more